Provides the 2025 appropriate use criteria for implantable cardioverter-defibrillators, cardiac resynchronization therapy, and pacing.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2025) studied this question. The 2025 multi-society Appropriate Use Criteria provide updated consensus guidance for utilizing implantable cardioverter-defibrillators, cardiac resynchronization therapy, and pacing.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: